The defendants admitted that they, or co-conspirators, entered into kickback arrangements with Medicare beneficiaries whereby the beneficiaries were paid every week in exchange for their Medicare billing information, thus allowing the clinics, which claimed to specialize in the treatment of HIV-positive patients, to submit fraudulent bills.
The defendants also admitted that none of the Medicare beneficiaries needed
the injection and infusion treatments billed to Medicare by the clinics. The phlebotomist admitted to administering unnecessary drugs intravenously to HIV patients.
Sentencing for the three defendants is scheduled for April 3; four co-defendants in the case are scheduled for trial beginning Feb. 9.
Read a news release from the U.S. attorney for the Southern District of Florida on the Miami Medicare fraud.
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
